Yuting Xie

2.5k total citations
78 papers, 939 citations indexed

About

Yuting Xie is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Yuting Xie has authored 78 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Genetics and 17 papers in Molecular Biology. Recurrent topics in Yuting Xie's work include Diabetes Management and Research (28 papers), Diabetes and associated disorders (20 papers) and Pancreatic function and diabetes (14 papers). Yuting Xie is often cited by papers focused on Diabetes Management and Research (28 papers), Diabetes and associated disorders (20 papers) and Pancreatic function and diabetes (14 papers). Yuting Xie collaborates with scholars based in China, United States and Japan. Yuting Xie's co-authors include Xia Li, Zhiguang Zhou, Fang Liu, Shuoming Luo, Chaoyuan Liu, Yiyu Zhang, Niu Huang, Li Li, Xiaobo Wan and Ting Zhong and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Yuting Xie

66 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuting Xie China 17 283 254 190 139 138 78 939
Wen Ye United States 18 394 1.4× 160 0.6× 59 0.3× 61 0.4× 83 0.6× 50 1.2k
Sarah J. Parker United States 26 796 2.8× 40 0.2× 201 1.1× 65 0.5× 117 0.8× 84 1.9k
Camilo Madariaga Orozco Colombia 11 803 2.8× 31 0.1× 192 1.0× 54 0.4× 55 0.4× 45 1.4k
Sandeep Khurana United States 22 512 1.8× 63 0.2× 43 0.2× 29 0.2× 322 2.3× 66 1.7k
Angela Alexander United States 22 1.4k 5.0× 189 0.7× 372 2.0× 58 0.4× 375 2.7× 55 2.6k
Yi Quan China 16 358 1.3× 26 0.1× 45 0.2× 27 0.2× 56 0.4× 54 856
Lars H. Breimer United Kingdom 19 1.3k 4.6× 108 0.4× 175 0.9× 47 0.3× 95 0.7× 68 2.1k
Tatjana Burchardt United States 22 476 1.7× 465 1.8× 84 0.4× 50 0.4× 141 1.0× 37 1.5k
Christine Delon United Kingdom 19 926 3.3× 111 0.4× 58 0.3× 24 0.2× 90 0.7× 28 1.4k

Countries citing papers authored by Yuting Xie

Since Specialization
Citations

This map shows the geographic impact of Yuting Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Xie more than expected).

Fields of papers citing papers by Yuting Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuting Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Xie. The network helps show where Yuting Xie may publish in the future.

Co-authorship network of co-authors of Yuting Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yuting Xie. A scholar is included among the top collaborators of Yuting Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuting Xie. Yuting Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Ziyan, Keli Yang, Yuting Xie, et al.. (2025). Nanozyme engineered ROS-tolerant cysteine active-site for upstream deubiquitylation therapy of inflammatory bowel disease. Nano Today. 62. 102735–102735.
2.
Xie, Yuting, et al.. (2025). From Voluntary to Mandatory: The Bibliometric and Meta‐Analytical Insights Into Effects of ESG Disclosure Practices and Regulations. Business Strategy and the Environment. 35(1). 1387–1402.
3.
Xie, Yuting, et al.. (2025). Structure-Based Optimization of TBK1 Inhibitors. ACS Medicinal Chemistry Letters. 16(4). 611–616.
5.
Xie, Yuting, Ke Wang, Yang Li, et al.. (2024). Porous hollow microspheres based on industrial solid waste enhance biomethane recovery from corn straw. Bioresource Technology. 412. 131395–131395. 1 indexed citations
6.
Xie, Yuting, et al.. (2024). Biological pretreatment and co-digestion strategies enhance the methane yield of waste wool. Chemical Engineering Journal. 502. 158089–158089. 3 indexed citations
7.
Yan, Yu‐Ting, Tao Liu, Yuting Xie, et al.. (2024). Structure-Based Identification of Organoruthenium Compounds as Nanomolar Antagonists of Cannabinoid Receptors. Journal of Chemical Information and Modeling. 64(3). 761–774. 3 indexed citations
8.
9.
Kang, Kang, Jingjing Xiang, Yuting Xie, et al.. (2024). N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension. Cellular & Molecular Biology Letters. 29(1). 69–69. 10 indexed citations
10.
Liu, Jingshuang, et al.. (2024). Implication of lncRNA MSTRG.81401 in Hippocampal Pyroptosis Induced by P2X7 Receptor in Type 2 Diabetic Rats with Neuropathic Pain Combined with Depression. International Journal of Molecular Sciences. 25(2). 1186–1186. 13 indexed citations
11.
Ma, Xinyou, Yuting Xie, Jinshan Tang, Jian Xue, & Zhanfen Chen. (2024). Two novel SNS-donor palladium(ii) complexes of benzoxazole and benzothiazole derivatives as potential anticancer agents. Dalton Transactions. 54(4). 1677–1688. 2 indexed citations
12.
Xie, Yuting. (2023). Analyzing the Shifts in Chinas Birth Rate: Unraveling the Factors Behind the Changes. Lecture Notes in Education Psychology and Public Media. 26(1). 58–66.
13.
Xie, Yuting, Yumin Meng, Linjie Li, et al.. (2023). In Silico Discovery of Small Molecule Modulators Targeting the Achilles’ Heel of SARS-CoV-2 Spike Protein. ACS Central Science. 9(2). 252–265. 24 indexed citations
14.
Zou, Kaiyong, Huang Huang, Haoran Zhuo, et al.. (2022). Etiology of lung cancer: Evidence from epidemiologic studies. SHILAP Revista de lepidopterología. 2(4). 216–225. 24 indexed citations
15.
Harding, Jessica L., Pandora L. Wander, Xinge Zhang, et al.. (2022). The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions. Diabetes Care. 45(4). 994–1006. 76 indexed citations
16.
Zou, Wenjing, Yuzhuo Liu, Jiang Zhu, et al.. (2021). Sustained Attention Deficits in Adults With Juvenile-Onset Type 1 Diabetes Mellitus. Psychosomatic Medicine. 83(8). 906–912. 4 indexed citations
17.
Xie, Yuting, et al.. (2020). Structure-Based Optimization of 10-DEBC Derivatives as Potent and Selective Pim-1 Kinase Inhibitors. Journal of Chemical Information and Modeling. 60(6). 3287–3294. 12 indexed citations
18.
Zhu, Jiang, Yuting Xie, Shichen Li, et al.. (2020). Effects of Diabetic Ketoacidosis on Executive Function in Children With Type 1 Diabetes: Evidence From Wisconsin Card Sorting Test Performance. Psychosomatic Medicine. 82(4). 359–365. 5 indexed citations
19.
Li, Wěi, Yuting Xie, Xiaobo Wan, et al.. (2019). Discovery of Novel Pim-1 Kinase Inhibitors with a Flexible-Receptor Docking Protocol. Journal of Chemical Information and Modeling. 59(10). 4116–4119. 10 indexed citations
20.
Wang, Yanli, Ran Cao, Dan Liu, et al.. (2017). In Silico Identification of a Novel Hinge-Binding Scaffold for Kinase Inhibitor Discovery. Journal of Medicinal Chemistry. 60(20). 8552–8564. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026